These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20182818)

  • 1. Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.
    Gérard N; Ceccarini J; Bormans G; Vanbilloen B; Casteels C; Goffin K; Bosier B; Lambert DM; Van Laere K
    J Mol Neurosci; 2010 Oct; 42(2):162-7. PubMed ID: 20182818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
    Casteels C; Vanbilloen B; Vercammen D; Bosier B; Lambert DM; Bormans G; Van Laere K
    Synapse; 2010 Aug; 64(8):617-23. PubMed ID: 20340169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
    Goffin K; Bormans G; Casteels C; Bosier B; Lambert DM; Grachev ID; Van Paesschen W; Van Laere K
    Neuropharmacology; 2008 Jun; 54(7):1103-6. PubMed ID: 18423778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study.
    Ceccarini J; Casteels C; Koole M; Bormans G; Van Laere K
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1582-94. PubMed ID: 23740372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.
    Casteels C; Bormans G; Van Laere K
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1164-73. PubMed ID: 20182714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.
    Casteels C; Martinez E; Bormans G; Camon L; de Vera N; Baekelandt V; Planas AM; Van Laere K
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2354-63. PubMed ID: 20680268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
    Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
    Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
    Van Laere K; Goffin K; Casteels C; Dupont P; Mortelmans L; de Hoon J; Bormans G
    Neuroimage; 2008 Feb; 39(4):1533-41. PubMed ID: 18077184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
    Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.
    Ceccarini J; Weltens N; Ly HG; Tack J; Van Oudenhove L; Van Laere K
    Transl Psychiatry; 2016 Jul; 6(7):e853. PubMed ID: 27404285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.
    Casteels C; Koole M; Celen S; Bormans G; Van Laere K
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1467-77. PubMed ID: 22699528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.
    Casteels C; Gérard N; van Kuyck K; Pottel L; Nuttin B; Bormans G; Van Laere K
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):308-21. PubMed ID: 24006151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
    Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
    Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.
    Gérard N; Pieters G; Goffin K; Bormans G; Van Laere K
    Biol Psychiatry; 2011 Oct; 70(8):777-784. PubMed ID: 21718968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
    Casteels C; Lauwers E; Baitar A; Bormans G; Baekelandt V; Van Laere K
    Brain Res; 2010 Feb; 1316():153-62. PubMed ID: 20026090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain.
    Sanabria-Bohórquez SM; Hamill TG; Goffin K; De Lepeleire I; Bormans G; Burns HD; Van Laere K
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):920-33. PubMed ID: 20033684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence.
    Ceccarini J; Hompes T; Verhaeghen A; Casteels C; Peuskens H; Bormans G; Claes S; Van Laere K
    J Neurosci; 2014 Feb; 34(8):2822-31. PubMed ID: 24553924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body biodistribution of the cannabinoid type 1 receptor ligand [
    Buchholz HG; Uebbing K; Maus S; Pektor S; Afahaene N; Weyer-Elberich V; Lutz B; Schreckenberger M; Miederer I
    Nucl Med Biol; 2017 Sep; 52():63-69. PubMed ID: 28648984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.